Navigating discrepancies: The assessment of residual lymphovascular invasion in breast carcinoma after neoadjuvant treatment
The assessment of residual lymphovascular invasion (LVI) in breast cancer patients undergoing neoadjuvant therapy may be a critical factor influencing prognosis and treatment decisions. However, there is a notable discrepancy between the RCB, UICC/AJCC, and ICCR guidelines regarding how LVI should b...
Saved in:
Main Authors: | Anikó Kovács, Åsa Rundgren-Sellei, Gunilla Rask, Annette Bauer, Anna Bodén, Johannes van Brakel, Eugenia Colón-Cervantes, Anna Ehinger, Johan Hartman, Balazs Acs |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2025-08-01
|
Series: | Breast |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S0960977625005363 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Predicting lymphovascular space invasion in early-stage cervical squamous cell carcinoma using heart rate variability
by: Junlong Fang, et al.
Published: (2025-07-01) -
Amide proton transfer-weighted habitat radiomics: a superior approach for preoperative prediction of lymphovascular space invasion in cervical cancer
by: Jie Li, et al.
Published: (2025-07-01) -
Primary operable breast cancer: molecular subtypes and morphological prognostic factors
by: V. E. Ponomarev, et al.
Published: (2019-06-01) -
Invasive solid papillary carcinoma with neuroendocrine differentiation of the breast: a case report and literature review
by: Xue Lin, et al.
Published: (2020-06-01) -
HER2 Reactivity Pattern and Association with Various Tumor Factors in Breast Cancer Patients
by: Greeshma Ann George, et al.
Published: (2025-04-01)